The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 25,601–25,700 of 31,469
Dozio, E., Tassistro, E., Orlando, A., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103862 · Cited by 3
Yoon, H.-B., Jang, Y., Paik, H.-G., Choi, H., Choi, J.-H., & Kwon, J. (2025) · Laboratory Animal Research · doi:10.1186/s42826-025-00234-w · Cited by 3
Lan, Y., Jin, B., Fan, Y., Huang, Y., & Zhou, J. (2025) · Biochemical Genetics · doi:10.1007/s10528-024-11010-1 · Cited by 3
Association between SPISE and NAFLD in patients with type 2 diabetes
Zhao, H., Ji, B., Wang, X., Shi, S., Sheng, J., Ma, X., Ban, B., & Gao, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1454938 · Cited by 3
The Role of Serum Free Fatty Acids in Endothelium‐Dependent Microvascular Function
Sullivan, A. E., Courvan, M. C., Aday, A. W., Wasserman, D. H., Niswender, K. D., Shardelow, E., Wells, E. K., Wells, Q. S., Freiberg, M. S., & Beckman, J. A. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70031 · Cited by 3
Ge, L., Cao, L., Wen, H., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02147-6 · Cited by 3
Elkordy, E. A., Zakaria, S. S., AlHussaini, K. I., & Sarhan, N. (2025) · Journal of Taibah University for Science · doi:10.1080/16583655.2025.2467479 · Cited by 3
Karaaslan, H., İnan, H., & Elmas, A. N. (2025) · Angiology · doi:10.1177/00033197251320147 · Cited by 3
Utzschneider, K. M., Tripputi, M., Butera, N. M., Mari, A., Rosin, S. P., Banerji, M. A., Bergenstal, R. M., Brown, N. M., Carlson, A. L., DeFronzo, R. A., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2419 · Cited by 4
Kaushik, A. S., Agarwal, V., Kumar, N., Rehman, M., Chaudhary, R., Srivastava, S., Srivastava, S., & Mishra, V. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151567 · Cited by 3
Biyikoglu, H., Robertson, M. D., & Collins, A. L. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03646-5 · Cited by 3
Kerlikowsky, F., Bartsch, M., Jonas, W., Hahn, A., & Schuchardt, J. P. (2025) · Marine Drugs · doi:10.3390/md23040139 · Cited by 3
Giovanelli, L., Bernardelli, G., Facchetti, S., Malacarne, M., Vandoni, M., Pellino, V. C., Zuccotti, G., Calcaterra, V., & Lucini, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320209 · Cited by 5
Busch, C. B. E., van den Hoek, K., van Baar, A. C. G., Meiring, S., Bouwmeester, T. A., Holleman, F., Nieuwdorp, M., & Bergman, J. J. G. H. M. (2025) · iGIE · doi:10.1016/j.igie.2025.03.012 · Cited by 3
Paules, E. M., VerHague, M., Lulla, A., Meyer, K. A., Coleman, M. F., Albright, J., Bennett, B. J., North, K. E., Howard, A.-G., Gordon‐Larsen, P., et al. (2025) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00220.2024 · Cited by 4
Associations between insulin resistance and low back pain risk in US adults: a cross-sectional study
Que, Z., Chen, D., Cai, H., Lan, W., Huang, Y., & Rui, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1538754 · Cited by 4
Mira-Martínez, S., Malih, N., Angullo-Martínez, E., Zamanillo‐Campos, R., Yáñez, A. M., Bennasar‐Veny, M., Gómez-Juanes, R., Konieczna, J., Jiménez, R., Serrano-Ripoll, M. J., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/70981 · Cited by 7
Kuang, X., Naiki‐Ito, A., Kawamura, H., Murakami, A., Komura, M., Kato, H., Nagayasu, Y., & Takahashi, S. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04075-3 · Cited by 4
Xiao, C., Xi, Y., Wang, X., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2850-y · Cited by 3
Carvalho, E., Landes, R. D., Cotter, M., Delhey, L. M., Børsheim, E., & Rose, S. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70090 · Cited by 2
Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes
Asuzu, P., Aliye, N., Stentz, F. B., Wan, J. Y., Mandal, N. A., & Dagogo-Jack, S. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf378 · Cited by 3
Zhao, H., Wang, Y., Liu, Y., Du, Z., & Tian, L. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70107 · Cited by 4
Ajiboye, B. O., Famusiwa, C. D., Oyedare, D. I., et al. (2024) · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology · doi:10.51847/9ls5ohuhiv · Cited by 3
Hartikainen, S., Vepsäläinen, V., Tompuri, T., et al. (2025) · EJNMMI Research · doi:10.1186/s13550-025-01278-8 · Cited by 3
Effects of Nighttime Eating Behavior on Cardiometabolic Health and Sleep: A Crossover Study
Kesgin, Y. E., Hasbal, N. B., Çöpür, S., İncir, S., Kurtulus, O., Genc, C., Yayci, E., Balcan, B., Akyıldız, M., Kanbay, A., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104217 · Cited by 3
Chauveau, L., Gonneaud, J., Poisnel, G., Landeau, B., Garnier‐Crussard, A., Pitel, A., Roquet, D., Touron, E., Haudry, S., Mézenge, F., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01808-5 · Cited by 4
Sosa, P., Angulo, J., Sánchez‐Ferrer, A., Gómez‐Cabrera, M. C., Fernández, A., Rodríguez‐Mañas, L., & Assar, M. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146783 · Cited by 3
Yanni, A. E., Kanata, M.-C., Papaioannou, V., Halabalaki, M., & Karathanos, V. Τ. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03759-x · Cited by 3
Tang, H., Lai, Y., Zhao, E., Zeng, W., Zhou, K., & Zhou, Z. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.07.048 · Cited by 4
Apostolaki, D., Katsibardi, Κ., Efthymiou, V., Stefanaki, C., Mantzou, A., Papadodima, S. A., Chrousos, G. P., Kattamis, A., & Bacopoulou, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14145098 · Cited by 3
Satheesh, G., Asokan, A. K., Vijayakumar, G., Chandran, M., Surendran, A., Simon, L., & Jaleel, A. (2025) · Metabolomics · doi:10.1007/s11306-025-02295-3 · Cited by 3
Sevilla-González, M. D. R., Hanson, P. A., Islam, J., Hsu, S. C., Tsoukas, M. A., Marliss, E. B., Reiner, A. P., Gravel, M., Kooperberg, C. L., Clish, C. B., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf454 · Cited by 3
Tarry, E. K., Vestergaard, S., Petersen, E. A., Olsen, M. C., Hansen, M., Ingersen, A., Connor, T., Pilegaard, H., Dela, F., Larsen, S., et al. (2025) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.70132 · Cited by 2
Application of the HOMA Index in Diabetic Dogs and Cats: A Systematic Review of Current Evidence
Hrițcu, L. D., Boghian, V., Pavel, G., Hriţcu, T.-D., Spataru, A., BURTAN, L. C., & Spataru, M. C. (2025) · Applied Sciences · doi:10.3390/app151910342 · Cited by 5
Circulating bile acids and HOMA-IR: cross-sectional results from the RoCAV population-based study
Grossi, S., Giusti, E. M., Veronesi, G., Delaiti, S., Mancini, A., Migliaccio, L., Genova, S., Costanzo, S., Tuohy, K. M., Ferrario, M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1656942 · Cited by 3
Euthyroid Nodular Disease in Relation to Insulin Resistance
Ahmad, O., Saghier, E., Abdel, Z., Hassan, B., Mahmoud, A., & Shawky, A. M. (2015) · Cited by 3
Multiplicidade de Fatores de Risco Cardiovascular em Crianças e Adolescentes de Guabiruba-SC, Brasil
da Silva, E. L., Rosini, N., Bruns, E. C. V., et al. (2015) · Revista de Saúde Pública de Santa Catarina · Cited by 3
ABNORMALNI TEST OPTEREĆENJA GLUKOZOM I BLAGI GESTACIJSKI DIJABETES
Kafkaslı, A., Sertkaya, A., Selçuk, E. B., et al. (2008) · Gynaecologia et perinatologia · Cited by 3
Kawamoto, R., Katoh, T., Kohara, K., & Miki, T. (2015) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2015.03.005 · Cited by 3
Diagnosis and Management of Horses with Equine Metabolic Syndrome (EMS)
Chameroy, K. A. (2010) · Cited by 3
Ryder, E., Mijac, V., Fernández, É., Trebols, N. M. P., Morales, M. C., Connell, L., Parra, A., Romero, M., & Fernández, N. (2014) · PubMed · Cited by 3
Bonora, E., Kiechl, S. J., Zoppini, G., et al. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0130 · Cited by 3
Subramaniam, S., Khan, H. B. H., Shanthi, P., et al. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1828-z · Cited by 3
Hemoglobin A1c in the Screening of Obesity-Related Diseases in Children and Adolescents
Song, M., 배재욱, Kim, Y. H., & Chung, S. (2012) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2012.17.2.92 · Cited by 3
Pérez-Fuentes, R., Báez-Duarte, B. G., Zamora‐Ginez, I., Ruiz‐Vivanco, G., Pulido‐Perez, P., Nieva-Vázquez, A., González-Mejía, M. E., & Torres‐Rasgado, E. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.01.007 · Cited by 3
Akt2 Gene common allelic variants in insulin resistance and the metabolic syndrome
Tassi, V., Coco, A., Padovano, L., Bonis, C. D., Cosmo, S. D., & Trischitta, V. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.005 · Cited by 3
Lee, S. W., Kim, M., Kim, H., et al. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.234.89 · Cited by 3
Giavoli, C., Profka, E., Sala, E., Filopanti, M., Barbieri, A. M., Bergamaschi, S., Ferrante, E., Arosio, M., Ambrosi, B., Lania, A. G., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0600 · Cited by 3
Popović, L., Lalic, K. S., Vasović, O., Radojković, D. D., Rajkovic, N., Singh, S., Stošić, L., Čivčić, M., Hinić, L. Š., & Vujić, T. P. (2014) · Journal of Medical Biochemistry · doi:10.2478/jomb-2014-0042 · Cited by 3
Dafopoulos, K. C., Vrekoussis, T., CHALVATZAS, N., Messini, C. I., Kalantaridou, S., Georgoulias, P., Messinis, I. E., & Makrigiannakis, A. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.07.1983 · Cited by 3
The Role of C-reactive Protein as a Inflammation-related Factor in Metabolic Syndrome
Park, J. S., Kim, Y. J., Lee, J. G., Kim, Y., Lee, S. Y., Min, H., & Cho, B. M. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.6.449 · Cited by 3
Lian, W.-C., Lin, J., Chang, J., Hsu, C., Pei, C., Wu, C., Hsieh, C., Pei, D., & Chen, Y. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0042 · Cited by 3
Response to an aerobic training intervention in young adults depends on ponderal index at birth
Brutsaert, T. D., Tamvada, K., Kiyamu, M., et al. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000177 · Cited by 3
Timon, I. M., Secades, I., & Botella-Carretero, J. I. (2007) · Revista Clínica Española · doi:10.1157/13100221 · Cited by 3
Sakai, K., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., et al. (2015) · Diabetology International · doi:10.1007/s13340-015-0202-6 · Cited by 3
Short-term response of metabolic hormones to coronary artery bypass surgery
Németh, Á., Cziráki, A., Sulyok, E., et al. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2014.04.002 · Cited by 3
Adipocytokine profiles as influenced by insulin resistance in obese subjects
Al‐Daghri, N. M., Al-Attas, O. S., & Sallam, R. M. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.02.004 · Cited by 3
Güldiken, S., Turgut, B., Demir, M., et al. (2006) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960601200109 · Cited by 3
Gredal, C., Rosenfalck, A. M., Dejgaard, A., & Hilsted, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802207982 · Cited by 3
Grasso, A., Malfatti, F., Andraghetti, G., et al. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/975695 · Cited by 3
Reliable Assessment of Insulin Resistance in Children
Name, M. A. V., & Caprio, S. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0315-z · Cited by 3
Simmons, R. K., Ko, G. T. C., Chan, J. C. N., Cockram, C. S., Nan, J. H., & Griffin, S. J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.07.002 · Cited by 3
Wassef, H., Davignon, J., Prud’homme, D., RABASA-LHORET, R. P. R., & Faraj, M. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.06.004 · Cited by 3
Alanine Aminotransferase as a Predictor of Metabolic Syndrome in Koreans
Kwon, J. H., An, Y. S., Kang, Y. H., Son, S. M., Kim, I. J., & Kim, Y. K. (2008) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.23.6.404 · Cited by 3
Mahadik, S. R., Lele, R. D., Mehtalia, S. D., et al. (2013) · PubMed · Cited by 3
Successful Internet-Based Lifestyle Change Program on Body Weight and Markers of Metabolic Health
Wyatt, H. R., Ogden, L. G., Cassic, K. S., et al. (2009) · Obesity and Weight Management · doi:10.1089/obe.2009.0406 · Cited by 3
WILDOVÁ, E., Dlouhý, P., Kraml, P. J., Rambousková, J., Šmejkalová, V., Potočková, J., & Anděl, M. (2013) · Physiological Research · doi:10.33549/physiolres.932462 · Cited by 3
Adiponectin complexes composition in Japanese-Brazilians regarding their glucose tolerance status
Crispim, F., Vendramini, M. F., the Japanese-Brazilian Diabetes Study Group, & Moisés, R. S. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-20 · Cited by 3
Galcheva, S., Martorana, D., Iotova, V., Yotov, Y. T., Neri, T. M., & Street, M. E. (2013) · PubMed · doi:10.3275/8972 · Cited by 3
Factor Analysis of Metabolic Syndrome among Iranian Male Smokers
Sarrafzadegan, N., Baghaei, A., Sadeghi, M., & Aminzadeh, A. (2005) · Iranian journal of medical sciences · Cited by 3
Echiburú, B., de Guevara, A. L., Pereira, C., Pérez, C., & Michael, P. (2014) · Revista médica de Chile · doi:10.4067/s0034-98872014000800003 · Cited by 4
Ibrahim, M. A., Sany, D., Shahawy, Y. E., & Awdallah, A. (2012) · Renal Failure · doi:10.3109/0886022x.2012.706877 · Cited by 3
Lee, S.-S. (2012) · Journal of Life Science · doi:10.5352/jls.2012.22.9.1261 · Cited by 3
Assessment of Biochemical Changes among Egyptian Women with Increased Body Weight
Afify, M., & Samy, N. (2012) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000127 · Cited by 3
Campos, G., Fernández, V., Fernández, É., Molero-Conejo, E., Morales, L. M., Raleigh, X., Connell, L., & Ryder, E. (2010) · PubMed · Cited by 3
Kamoi, K., & Sasaki, H. (2014) · Internal Medicine Open Access · doi:10.4172/2165-8048.s6-004 · Cited by 3
Insulin Resistance Predicts Virological Response to Interferon-α in Chronic Hepatitis B Patients
Wang, X., Zhao, Y.-R., Liu, H., Ma, X.-H., Zhang, Y., & Yi, R. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000452 · Cited by 3
Ciresi, A., Amato, M. C., Bianco, J., & Giordano, C. S. D. S. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0423 · Cited by 3
Yang, H. K., Ha, H., Rhee, M., Lee, J., Park, Y., Kwon, H., Yim, H., Kang, M., Lee, W., Son, H., et al. (2016) · Medicine · doi:10.1097/md.0000000000003053 · Cited by 4
Magri, C. J., Calleja, N., Buhagiar, G., Fava, S., & Vassallo, J. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.104216 · Cited by 3
The metabolic syndrome in normal weight Malay subjects
Al-Mahmood, A. K., Ismail, A. A.-S., Faridah, A. R., et al. (2016) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v15i1.27149 · Cited by 3
Weight loss-induced increases in osteocalcin are associated with improvements in glucose homeostasis
Hinton, P. S., Thyfault, J. P., & Thomas, T. R. (2011) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.s1-002 · Cited by 3
Pancreatic Abnormalities at a Young Age in Spontaneously Diabetic Torii (SDT) Rats
Yamada, T., Ohta, T., Shinohara, M., & Yamamoto, T. (2012) · Journal of Animal and Veterinary Advances · doi:10.3923/javaa.2012.1322.1326 · Cited by 3
Insulin-related metabolic and endocrine effects of valproate in patients with epilepsy
Pylvänen, V. (2005) · Cited by 3
Insulin resistance in drug naive patients with multiple sclerosis
Kostić, S., Kolić, I., Raičević, R., Stojanović, Z., Kostić, D., & Dinčić, E. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp160218082k · Cited by 3
Factors Influencing Elevated Serum Apolipoprotein B48 in Diabetic and Control Participants
Leonard, A., Tun, T. K., Gaffney, P. R., Sharma, J., Gibney, J., & Boran, G. P. (2014) · British Journal of Biomedical Science · doi:10.1080/09674845.2014.11669979 · Cited by 3
Alizadeh, A. A., Farhad, R., Mohebbi, H., & Zakerkish, M. (2015) · Iranian journal of diabetes and obesity · Cited by 3
Hurtado, L. H., Sanchez-Margallo, F. M., Vigo, J. L. D. L. C., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2223-z · Cited by 3
Beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes
Zelada, H., Carnero, A. M., Hurtado, C. J. M., Aliaga, D. I. C., Munarriz, C. A. L., Aro, P., & Manrique, H. A. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.05.003 · Cited by 3
Eslam, M., Aparcero, R., & Romero‐Gómez, M. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31578-9 · Cited by 3
Risk assessment chart for predicting fatty liver in Japanese subjects.
Inabe, F., Takahashi, E., Moriyama, K., Negami, M., & Otsuka, H. (2012) · PubMed · Cited by 3
Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4
Abdel‐Razik, A., Mousa, N., Abdel-Aziz, M., et al. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000534 · Cited by 3
Ramírez-Murillo, C., Guillot-Sánchez, E., & B, E. A. O. Q. (2015) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000181 · Cited by 3
Birdee, G. S. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000588 · Cited by 3
Rokeya, B. (2016) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000179 · Cited by 3
Ходырев, Д. С., Nikitin, A. G., Бровкин, А. Н., Лаврикова, Е. Ю., Лебедева, Н. О., Vikulova, O. K., Шамхалова, М. Ш., Shestakova, M. V., Mayorov, M. Y., Potapov, V. A., et al. (2016) · Russian Journal of Genetics · doi:10.1134/s1022795416110065 · Cited by 3
Castillo-Hernández, J., Cervantes, M. I. M., Reyes, J. P., Marín, N. P., Cervantes, E. M., Solorzano‐Rodriguez, C., Mendoza, E. D. L. C., & Alvarado‐Sánchez, B. (2016) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2016.10.005 · Cited by 3
Young, healthy South Asians have enhanced lipogenic sensitivity to dietary sugar
Hudgins, L. C., Hugo, J. L., Enayat, S., Parker, T. S., Artis, A. S., & Levine, D. M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13293 · Cited by 2
Kim, Y.-H., Park, C. M., & Yoon, G.-A. (2016) · Journal of Nutrition and Health · doi:10.4163/jnh.2016.49.6.411 · Cited by 3
Doğan, H. O. (2017) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/223.v39i29491.316368 · Cited by 3
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
